Expanding genetic testing for cancer risk in patients and families
Official title: Innovative Approaches to Expand Cancer Genetic Screening and Testing for Patients & Families in a Statewide Oncology Network through Community, State, & Payer Partnerships
Funded at University of Michigan at Ann Arbor · NIH-9848358 · Data updated 2026-11-12
This study is working to make it easier for cancer patients in Michigan to get genetic testing for cancer risk by improving how doctors gather family history and assess genetic risks, so that more people can receive the important evaluations they need.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | June 8, 2020 |
| Project end | May 31, 2026 |
| Funding year | 2020 |
| Award (this year) | $3,955,535 |
| NIH project number | 1U01CA232827-01A1 |
| Project ID | NIH-9848358 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include newly diagnosed cancer patients, particularly those with breast, colorectal, ovarian, prostate, and endometrial cancers, who may have hereditary cancer syndromes.
✕Less likely to help
Patients who do not have a family history of cancer or those diagnosed with cancers not included in the study may not benefit from this research.
What this research studies
This research aims to improve access to genetic testing for cancer risk by addressing barriers that prevent patients from undergoing necessary evaluations. It involves a multiphase approach that includes both practice-level and patient-level interventions to enhance the documentation of family histories and the assessment of genetic risks among newly diagnosed cancer patients. By collaborating with a statewide oncology network and public health agencies, the project seeks to implement systematic strategies to ensure that eligible patients receive guideline-concordant genetic evaluations across various medical practices in Michigan.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of patients who receive appropriate genetic testing, leading to better cancer prevention and treatment strategies.
How similar studies have gone: Previous research has shown that similar community-based interventions can effectively increase genetic testing rates among at-risk populations.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Stoffel, Elena Martinez — University of Michigan at Ann Arbor
- Study coordinator: Stoffel, Elena Martinez
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.